These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 25782319)

  • 1. [The influence of combined therapy with calcium antagonist and angiotensin-converting enzyme inhibitor on the circadian profile of arterial pressure in patients with arterial hypertension in the Far North].
    Zapesochnaia IL; Avtandilov AG
    Klin Med (Mosk); 2014; 92(10):33-40. PubMed ID: 25782319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [DYNAMICS OF THE CIRCADIAN BLOOD PRESSURE PROFILE DURING COMBINED AMLODIPINE-VALSARTAN THERAPY IN FAR NORTH RESIDENTS].
    Zapesochnaya IL; Avtandilov AG
    Klin Med (Mosk); 2015; 93(5):43-9. PubMed ID: 26410959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD; Mion D; Rocha JC; Kohlmann O; Gomes MA; Saraiva JF; Amodeo C; Filho BL
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the renin-angiotensin system or calcium channel blockade on the circadian variation of heart rate variability, blood pressure and circulating catecholamines in hypertensive patients.
    Karas M; Lacourcière Y; LeBlanc AR; Nadeau R; Dubé B; Florescu M; Lamarre-Cliche M; Poirier L; Larochelle P; de Champlain J
    J Hypertens; 2005 Jun; 23(6):1251-60. PubMed ID: 15894902
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparative study of spirapril (quadropril) and amlodipine efficacy. Results of randomized trial in patients with mild to moderate arterial hypertension].
    Shal'nova SA; Martsevich SIu; Deev AD; Kutishenko NP; Kukushkin SK; Manoshkina EM; Alimova EV; Semenova IuE; Lebedev AV; Koniakhina IP; Zagrebel'nyĭ AV
    Ter Arkh; 2000; 72(10):86-9. PubMed ID: 11220888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The study of effects of ramipril and amlodipine combination in patients with arterial hypertension and type 2 diabetes mellitus].
    Tkacheva ON; Barabashkina AV; Novikova IM; Runikhina NK
    Kardiologiia; 2009; 49(5):40-7. PubMed ID: 19463134
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possibilities of rational combination antihypertensive therapy: results of HEMERA international clinical trial].
    Chazova IE; Martyniuk TV
    Ter Arkh; 2013; 85(10):10-22. PubMed ID: 24437213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beneficial effects of combination therapy with angiotensin II receptor blocker and angiotensin-converting enzyme inhibitor on vascular endothelial function.
    Morimoto S; Maki K; Aota Y; Sakuma T; Iwasaka T
    Hypertens Res; 2008 Aug; 31(8):1603-10. PubMed ID: 18971536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of graded-release diltiazem versus ramipril, dosed at bedtime, on early morning blood pressure, heart rate, and the rate-pressure product.
    White WB; Lacourciere Y; Gana T; Pascual MG; Smith DH; Albert KS
    Am Heart J; 2004 Oct; 148(4):628-34. PubMed ID: 15459593
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
    Jamerson KA; Nwose O; Jean-Louis L; Schofield L; Purkayastha D; Baron M
    Am J Hypertens; 2004 Jun; 17(6):495-501. PubMed ID: 15177521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparative efficiency of indapamide combinations with various derivaties of calcium antagonists in patients with arterial hypertension].
    Iskenderov BG; Sisina ON; Gridneva EV; Lokhina TV
    Klin Med (Mosk); 2010; 88(1):54-8. PubMed ID: 20369614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ACE inhibitor-based, directly observed therapy for hypertension in hemodialysis patients.
    Zheng S; Nath V; Coyne DW
    Am J Nephrol; 2007; 27(5):522-9. PubMed ID: 17700014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of mild-to-moderate hypertension with calcium channel blockers: a multicentre comparison of once-daily nifedipine GITS with once-daily amlodipine.
    Kes S; Caglar N; Canberk A; Deger N; Demirtas M; Dortlemez H; Kiliccioglu B; Kozan O; Ovunc K; Turkoglu C
    Curr Med Res Opin; 2003; 19(3):226-37. PubMed ID: 12803737
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiovascular effects of a low-dose combination of ramipril and felodipine in spontaneously hypertensive rats.
    Mervaala EM; Teräväinen TL; Malmberg L; Laakso J; Vapaatalo H; Karppanen H
    Br J Pharmacol; 1997 Jun; 121(3):503-10. PubMed ID: 9179393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amlodipine and angiotensin-converting enzyme inhibitor combination versus amlodipine monotherapy in hypertension: a meta-analysis of randomized controlled trials.
    Lv Y; Zou Z; Chen GM; Jia HX; Zhong J; Fang WW
    Blood Press Monit; 2010 Aug; 15(4):195-204. PubMed ID: 20512032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combination therapy of angiotensin II receptor blocker and calcium channel blocker exerts pleiotropic therapeutic effects in addition to blood pressure lowering: amlodipine and candesartan trial in Yokohama (ACTY).
    Maeda A; Tamura K; Kanaoka T; Ohsawa M; Haku S; Azushima K; Dejima T; Wakui H; Yanagi M; Okano Y; Fujikawa T; Toya Y; Mizushima S; Tochikubo O; Umemura S
    Clin Exp Hypertens; 2012; 34(4):249-57. PubMed ID: 22571446
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A comparison of the effect of Capoten (captopril) and ramipril on the circadian profile of the arterial pressure and peripheral hemodynamics in patients with hypertension combined with diabetes mellitus].
    Filatova EV; Vikhert OA; Rogoza AN; Arabidze GG; Kukharchuk VV
    Ter Arkh; 1996; 68(5):67-70. PubMed ID: 9082606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Switching therapy to bedtime for uncontrolled hypertension with a nondipping pattern: a prospective randomized-controlled study.
    Farah R; Makhoul N; Arraf Z; Khamisy-Farah R
    Blood Press Monit; 2013 Aug; 18(4):227-31. PubMed ID: 23660686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combinations of inhibitors of the renin-angiotensin system with calcium channel blockers for the treatment of hypertension: focus on perindopril/amlodipine.
    Mourad JJ; Le Jeune S; Pirollo A; Mourad C; Gaudouen Y; Lopez-Sublet M
    Curr Med Res Opin; 2010 Sep; 26(9):2263-76. PubMed ID: 20690889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of fixed-dose combination of amlodipine/benazepril in Chinese essential hypertensive patients not adequately controlled with benazepril monotherapy: a multicenter, randomized, double-blind, double-dummy, parallel-group clinical trial.
    Yan P; Fan W;
    Clin Exp Hypertens; 2014; 36(4):268-74. PubMed ID: 23859303
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.